Gomisin N

CAT:
804-HY-N6866-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Gomisin N - image 1

Gomisin N

  • Description:

    Gomisin N is an orally active lignan compound. Gomisin N can be isolated from Schisandra chinensis. Gomisin N induces Apoptosis in a variety of cells. Gomisin N activates AMPK, Akt, MAPK/ERK, Nrf2, caspase-3 and PARP-1. Gomisin N inhibits GSK3β, nitric oxide (NO), and proinflammatory cytokines (IL-1β, IL-6, TNF-α) . Gomisin N has anti-inflammatory, antioxidant, anti-obesity, anti-diabetic, and anti-melanogenesis activities. Gomisin N has anti-tumor activity against cervical cancer and liver cancer. Gomisin N improves Alzheimer's disease[1][2][3][4][5][6][7][8][9][10].
  • UNSPSC:

    12352005
  • Hazard Statement:

    H302, H315, H319, H335
  • Target:

    Akt; AMPK; Apoptosis; Caspase; GSK-3; Interleukin Related; Keap1-Nrf2; NO Synthase; PARP; PERK
  • Type:

    Natural Products
  • Related Pathways:

    Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Immunology/Inflammation; NF-κB; PI3K/Akt/mTOR; Stem Cell/Wnt
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    Cancer; Endocrinology; Metabolic Disease; Inflammation/Immunology; Neurological Disease
  • Assay Protocol:

    https://www.medchemexpress.com/gomisin-n.html
  • Concentration:

    10mM
  • Purity:

    99.94
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles:

    COC1=C2OCOC2=CC(C[C@@H]3C)=C1C(C(C[C@H]3C)=CC(OC)=C4OC)=C4OC
  • Molecular Formula:

    C23H28O6
  • Molecular Weight:

    400.46
  • Precautions:

    H302, H315, H319, H335
  • References & Citations:

    [1]Inoue H, et al. Gomisin N enhances TRAIL-induced apoptosis via reactive oxygen species-mediated up-regulation of death receptors 4 and 5. Int J Oncol. 2012 Apr;40 (4) :1058-65.|[2]Jung DY, et al. Antidiabetic effect of gomisin N via activation of AMP-activated protein kinase. Biochem Biophys Res Commun. 2017 Dec 16;494 (3-4) :587-593.|[3]Oh SY, et al. Anti-inflammatory effects of gomisin N, gomisin J, and schisandrin C isolated from the fruit of Schisandra chinensis. Biosci Biotechnol Biochem. 2010;74 (2) :285-91.|[4]Jang MK, et al. Gomisin N inhibits adipogenesis and prevents high-fat diet-induced obesity. Sci Rep. 2017 Jan 9;7:40345.|[5]Zhu PL, et al. Gomisin N Exerts Anti-liver Cancer Effects and Regulates PI3K-Akt and mTOR-ULK1 Pathways in Vitro. Biol Pharm Bull. 2020;43 (8) :1267-1271.|[6]Yim SY, et al. Gomisin N isolated from Schisandra chinensis significantly induces anti-proliferative and pro-apoptotic effects in hepatic carcinoma. Mol Med Rep. 2009 Sep-Oct;2 (5) :725-32. |[7]Takimoto Y, et al. Gomisin N in the herbal drug gomishi (Schisandra chinensis) suppresses inducible nitric oxide synthase gene via C/EBPβ and NF-κB in rat hepatocytes. Nitric Oxide. 2013 Jan 15;28:47-56.|[8]Jang MK, et al. Protective Effect of Gomisin N against Endoplasmic Reticulum Stress-Induced Hepatic Steatosis. Biol Pharm Bull. 2016 May 1;39 (5) :832-8.|[9]Chae JK, et al. Gomisin N Inhibits Melanogenesis through Regulating the PI3K/Akt and MAPK/ERK Signaling Pathways in Melanocytes. Int J Mol Sci. 2017 Feb 22;18 (2) :471.|[10]Song M, et al. Gomisin N rescues cognitive impairment of Alzheimer's disease by targeting GSK3β and activating Nrf2 signaling pathway. Phytomedicine. 2024 Sep;132:155811.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, protect from light)
  • Scientific Category:

    Natural Products
  • Clinical Information:

    No Development Reported
  • Isoform:

    Caspase 3; GSK-3β; IL-1; IL-6; PARP1
  • CAS Number:

    [69176-52-9]